Lv1
50 积分 2024-10-23 加入
Epigenetic regulation of chromosomal instability by EZH2 methyltransferase
1个月前
已完结
Inhibitors of oncogenic Kras specificall prime CTLA4 blockade to transcriptionally reprogram Tregs and overcome resistance to suppress pancreas cancer
3个月前
已完结
Combined KRAS inhibition and immune therapy generates durable complete responses in an autochthonous PDAC model
4个月前
已完结
JAB-3312, a Potent Allosteric SHP2 Inhibitor that Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade Therapies
4个月前
已完结
Combined KRAS inhibition and immune therapy generates durable complete responses in an autochthonous PDAC model
4个月前
已完结
Combined KRAS inhibition and immune therapy generates durable complete responses in an autochthonous PDAC model
5个月前
已完结
Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling
5个月前
已完结
Development of RMC-6236, a potent and orally bioavailable RAS(ON) multi-selective tri-complex inhibitor for the treatment of RAS-addicted cancers by targeting multiple RAS variants
5个月前
已完结
Pan-cancer analysis of oncogenic MET fusions reveals distinct pathogenomic subsets with differential sensitivity to MET-targeted therapy
5个月前
已完结
CellofOriginInfluencesPancreaticCancerSubtype
6个月前
已完结
皖公网安备34019202002308
